Additionally, the activation of PKD1 using natural compounds like curcumin or Bryostatin-1, in concurrence with the observed tumor suppressor function for PKD1, also leads to decreased nuclear β-catenin functions and lower cell proliferation in prostate cancer cells [19, 31]. Here, PKD1 is linked to prostate carcinoma.